Invention Grant
US07919101B2 Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors
有权
人类免疫缺陷病毒（HIV）融合抑制剂的高效协同组合
- Patent Title: Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors
- Patent Title (中): 人类免疫缺陷病毒（HIV）融合抑制剂的高效协同组合
-
Application No.: US12540325Application Date: 2009-08-12
-
Publication No.: US07919101B2Publication Date: 2011-04-05
- Inventor: Shibo Jiang , Chungen Pan
- Applicant: Shibo Jiang , Chungen Pan
- Applicant Address: US NY New York
- Assignee: New York Blood Center
- Current Assignee: New York Blood Center
- Current Assignee Address: US NY New York
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Michelle Glasky Bergman
- Main IPC: A61K39/21
- IPC: A61K39/21
Abstract:
Provided herein are pharmaceutical compositions for the prophylactic and therapeutic treatment of HIV comprising combinations of HIV fusion/entry inhibitors that exhibit synergistic effect, including T-20 (enfuvirtide), T-1249, T-1144, C34, and sifuvirtide. Also disclosed are methods of treating HIV infection by administering such compositions.
Public/Granted literature
- US20100040631A1 Combination Therapy of HIV Using Fusion/Entry Inhibitors Targeting GP41 Public/Granted day:2010-02-18
Information query
